Abbonarsi

Current insights into the genetics of food allergy - 09/01/21

Doi : 10.1016/j.jaci.2020.10.039 
Kanika Kanchan, PhD a, Selene Clay, BA b, Haritz Irizar, PhD c, d, Supinda Bunyavanich, MD, MPH d, e, Rasika A. Mathias, ScD a,
a Division of Allergy and Clinical Immunology, Department of Medicine, Johns Hopkins University, Baltimore, Md 
b Department of Human Genetics, The University of Chicago, Chicago, Ill 
c Division of Psychiatry, University College London, London, United Kingdom 
d Department of Genetics & Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 
e Division of Allergy & Immunology, Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY 

Corresponding author: Rasika A. Mathias, ScD, Division of Allergy and Clinical Immunology, 5501 Hopkins Bayview Circle, 3A.62A Baltimore, MD 21224.Division of Allergy and Clinical Immunology5501 Hopkins Bayview Circle3A.62ABaltimoreMD21224

Abstract

Food allergy (FA), a growing public health burden in the United States, and familial aggregation studies support strong roles for both genes and environment in FA risk. Deepening our understanding of the molecular and cellular mechanisms driving FAs is paramount to improving its prevention, diagnosis, and clinical management. In this review, we document lessons learned from the genetics of FA that have aided our understanding of these mechanisms. Although current genetic association studies suffer from low power, heterogeneity in definition of FA, and difficulty in our ability to truly disentangle FA from food sensitization (FS) and general atopy genetics, they reveal a set of genetic loci, genes, and variants that continue to implicate the importance of barrier and immune function genes across the atopic march, and FA in particular. The largest reported effects on FA are from MALT1 (odds ratio, 10.99), FLG (average odds ratio, ∼2.9), and HLA (average odds ratio, ∼2.03). The biggest challenge in the field of FA genetics is to elucidate the specific mechanism of action on FA risk and pathogenesis for these loci, and integrative approaches including genetics/genomics with transcriptomics, proteomics, and metabolomics will be critical next steps to translating these genetic insights into practice.

Il testo completo di questo articolo è disponibile in PDF.

Key words : Food allergy, peanut allergy, genetics, genomics, barrier genes, immune genes, atopic march, Dual Allergen hypothesis, FLG, HLA

Abbreviations used : AD, AR, CGAS, CMA, DZ, EA, EDC, EoE, FA, FLG, FS, GOFA, GWAS, G × E, LD, LEAP, LOF, MZ, NR, OFC, OR, PA, ps, sIgE, SNP


Mappa


 K.K. and R.A.M. are supported in part by the Immune Tolerance Network, an international clinical research consortium headquartered at the Benaroya Research Institute, and by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) (award no. UM1AI109565). H.I. and S.B. are supported in part by the NIH (grant nos. NIH R01 AI 147028, U19 AI 136053, and R01 AI118833). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
 Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest.
 Terms in boldface and italics are detailed in the glossary on page 16.


© 2020  American Academy of Allergy, Asthma & Immunology. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 147 - N° 1

P. 15-28 - Gennaio 2021 Ritorno al numero
Articolo precedente Articolo precedente
  • Integrating oral immunotherapy into clinical practice
| Articolo seguente Articolo seguente
  • EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: Definitions and management
  • Claus Bachert, Joe K. Han, Martin Wagenmann, Werner Hosemann, Stella E. Lee, Vibeke Backer, Joaquim Mullol, Philippe Gevaert, Ludger Klimek, Emanuel Prokopakis, Andrew Knill, Carlo Cavaliere, Claire Hopkins, Peter Hellings

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.